Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

UPLC/MS for the identification of beta-blockers.

Stephen A C Wren1, Pierre Tchelitcheff

  • 1Analytical Development, PAR&D, AstraZeneca, Silk Business Park, Macclesfield, Cheshire SK10 2NA, UK. stephen.wren@astrazeneca.com

Journal of Pharmaceutical and Biomedical Analysis
|January 18, 2006
PubMed
Summary

Ultra-Performance Liquid Chromatography coupled with Mass Spectrometry (UPLC/MS) offers better separation for analyzing beta-blockers compared to High-Performance Liquid Chromatography (HPLC/MS). Both methods provide comparable mass spectral quality for these crucial cardiovascular drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring apoptosis in intact cells by high-resolution magic angle spinning <sup>1</sup> H NMR spectroscopy.

NMR in biomedicine·2021
Same author

NMR and Thermal Studies for the Characterization of Mass Transport and Phase Separation in Paracetamol/Copovidone Hot-Melt Extrusion Formulations.

Molecular pharmaceutics·2020
Same author

Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release.

Molecular pharmaceutics·2016
Same author

Investigating the Dissolution Performance of Amorphous Solid Dispersions Using Magnetic Resonance Imaging and Proton NMR.

Molecules (Basel, Switzerland)·2015
Same author

Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.

Molecular pharmaceutics·2015
Same author

Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.

Journal of controlled release : official journal of the Controlled Release Society·2014

Area of Science:

  • Analytical Chemistry
  • Pharmacology
  • Mass Spectrometry

Background:

  • Beta-blockers are essential cardiovascular medications.
  • Accurate analytical methods are crucial for quality control and research.
  • Liquid chromatography coupled with mass spectrometry (LC/MS) is a standard technique for drug analysis.

Purpose of the Study:

  • To compare the analytical performance of UPLC/MS and HPLC/MS for beta-blocker analysis.
  • To evaluate separation efficiency and mass spectral quality for a panel of beta-blockers.

Main Methods:

  • Analysis of seven beta-blockers (Oxprenolol, Metoprolol, Acebutolol, Atenolol, Propranolol, Pindolol, and Alprenolol).
  • Utilized both Ultra-Performance Liquid Chromatography/Mass Spectrometry (UPLC/MS) and High-Performance Liquid Chromatography/Mass Spectrometry (HPLC/MS).

Related Experiment Videos

  • Employed mobile phases containing acetonitrile, trifluoroacetic acid (TFA), and either H2O or D2O.

    • Main Results:

    • UPLC/MS demonstrated superior chromatographic separation performance compared to HPLC/MS.
    • The mass spectral quality obtained from UPLC/MS was comparable to that from HPLC/MS.
    • Effective analysis of diverse beta-blocker compounds was achieved.

    Conclusions:

    • UPLC/MS is a highly effective technique for the analysis of beta-blockers, offering enhanced separation.
    • The method provides reliable mass spectral data suitable for identification and quantification.
    • This analytical approach can be valuable for pharmaceutical analysis and quality control of beta-blocker drugs.